NL8005577A - Werkwijze voor het bereiden van een vaccin. - Google Patents
Werkwijze voor het bereiden van een vaccin. Download PDFInfo
- Publication number
- NL8005577A NL8005577A NL8005577A NL8005577A NL8005577A NL 8005577 A NL8005577 A NL 8005577A NL 8005577 A NL8005577 A NL 8005577A NL 8005577 A NL8005577 A NL 8005577A NL 8005577 A NL8005577 A NL 8005577A
- Authority
- NL
- Netherlands
- Prior art keywords
- vaccine
- virus
- poultry
- genus
- vgnki
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims description 96
- 238000000034 method Methods 0.000 title claims description 30
- 241000700605 Viruses Species 0.000 claims description 59
- 241000287828 Gallus gallus Species 0.000 claims description 46
- 201000010099 disease Diseases 0.000 claims description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 24
- 238000002360 preparation method Methods 0.000 claims description 22
- 241000271566 Aves Species 0.000 claims description 16
- 210000002257 embryonic structure Anatomy 0.000 claims description 14
- 230000004071 biological effect Effects 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 11
- 241000711404 Avian avulavirus 1 Species 0.000 claims description 10
- 230000001681 protective effect Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 6
- 210000001161 mammalian embryo Anatomy 0.000 claims description 6
- 238000009395 breeding Methods 0.000 claims description 4
- 230000001488 breeding effect Effects 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 208000011090 bird disease Diseases 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims 1
- 244000144977 poultry Species 0.000 description 47
- 235000013594 poultry meat Nutrition 0.000 description 47
- 235000013330 chicken meat Nutrition 0.000 description 44
- 241001465754 Metazoa Species 0.000 description 27
- 238000002255 vaccination Methods 0.000 description 23
- 210000001331 nose Anatomy 0.000 description 17
- 238000010790 dilution Methods 0.000 description 13
- 239000012895 dilution Substances 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 12
- 210000004400 mucous membrane Anatomy 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 230000036039 immunity Effects 0.000 description 9
- 230000003053 immunization Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 235000012206 bottled water Nutrition 0.000 description 7
- 239000003651 drinking water Substances 0.000 description 7
- 238000002649 immunization Methods 0.000 description 7
- 230000005847 immunogenicity Effects 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000010359 Newcastle Disease Diseases 0.000 description 6
- 239000000443 aerosol Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000002163 immunogen Effects 0.000 description 5
- 230000004083 survival effect Effects 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 4
- 210000002845 virion Anatomy 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000035931 haemagglutination Effects 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000011321 prophylaxis Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 208000027954 Poultry disease Diseases 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- 238000001856 aerosol method Methods 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000012770 revaccination Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 101000576973 Homo sapiens Mitochondrial-processing peptidase subunit beta Proteins 0.000 description 1
- 244000116484 Inula helenium Species 0.000 description 1
- 102100025298 Mitochondrial-processing peptidase subunit beta Human genes 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU792833299A SU826584A1 (ru) | 1979-10-29 | 1979-10-29 | Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц |
| SU2833299 | 1979-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8005577A true NL8005577A (nl) | 1981-06-01 |
Family
ID=20856462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8005577A NL8005577A (nl) | 1979-10-29 | 1980-10-09 | Werkwijze voor het bereiden van een vaccin. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4279893A (fr) |
| CA (1) | CA1159366A (fr) |
| DE (1) | DE3034238A1 (fr) |
| DK (1) | DK453880A (fr) |
| GB (1) | GB2062461B (fr) |
| NL (1) | NL8005577A (fr) |
| SU (1) | SU826584A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ224567A (en) * | 1987-05-19 | 1990-08-28 | Yissum Res Dev Co | Vaccine against newcastle disease virus comprising a live immunogenic lentogenic or mesogenic strain of newcastle disease virus in combination with a liquid containing a mineral or vegetable oil |
| ES2060740T3 (es) * | 1988-07-18 | 1994-12-01 | Duphar Int Res | Vacunas de virus vivos para la enfermedad de newcastle. |
| US5118502A (en) * | 1989-06-20 | 1992-06-02 | The University Of Georgia Research Foundation, Inc. | Naturally attenuated newcastle disease vaccine and method of using the same |
| US5427791A (en) * | 1992-08-05 | 1995-06-27 | Regents Of The University Of Minnesota | Embryonal vaccine against Newcastle disease |
| US5753228A (en) * | 1992-08-25 | 1998-05-19 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies |
| CA2181862C (fr) * | 1995-08-01 | 2009-12-22 | Carla Christina Schrier | Vaccin antiviral attenue pour la maladie de newcastle |
| IL139538A0 (en) * | 1998-05-15 | 2004-02-08 | Mkb Invest Ltd Partnership | Compositions and method for immunizing poultry |
| US6517844B1 (en) | 1999-05-14 | 2003-02-11 | Marshall K. Brinton | Compositions and method for immunizing polutry |
| RU2378013C1 (ru) * | 2008-09-26 | 2010-01-10 | ГНУ ВНИИ ветеринарной вирусологии и микробиологии | Способ изготовления вирусвакцины против ньюкаслской болезни птиц для орального применения |
| KR101258619B1 (ko) * | 2010-07-12 | 2013-04-29 | 대한민국 | 새로운 약독형 유전아형의 뉴캣슬병 바이러스 백신주 및 이를 포함하는 뉴캣슬병 바이러스 백신 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2767117A (en) * | 1953-10-22 | 1956-10-16 | Crawley John Frederick | Poultry virus vaccine products and method of preparing the same |
| US2798835A (en) * | 1954-01-18 | 1957-07-09 | American Cyanamid Co | Newcastle disease and infectious bronchitis vaccines and production thereof |
| US3060094A (en) * | 1959-04-07 | 1962-10-23 | Ray M Dutcher | Preparation of virus vaccines |
| US3029190A (en) * | 1959-08-04 | 1962-04-10 | Hanson Robert Paul | Selection of neurotropic viral strains and preparation of vaccines therefrom |
| GB1010509A (en) * | 1962-02-23 | 1965-11-17 | Pfizer Ltd | Improvements in or relating to newcastle disease virus vaccines |
| DE1617457A1 (de) * | 1966-12-16 | 1972-04-20 | Erba Carlo Spa | Verfahren zur Stabilisierung von Zubereitungen interferierender Virusprodukte |
| US3548054A (en) * | 1969-06-06 | 1970-12-15 | Lilly Co Eli | Method for improving weight gains and reducing gross lesions in chickens exposed to marek's disease |
| DK124340B (da) * | 1969-11-29 | 1972-10-09 | Takeda Chemical Industries Ltd | Fremgangsmåde til fremstilling af stærk svækket, levende Newcastle-syge-virus-vaccine. |
| US3876763A (en) * | 1970-12-29 | 1975-04-08 | Shionogi & Co | Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof |
| US4071618A (en) * | 1974-09-03 | 1978-01-31 | Research Foundation For Microbial Diseases Of Osaka University | Process for preparing virus disease live vaccines |
| US4053583A (en) * | 1976-03-01 | 1977-10-11 | Smithkline Corporation | Live newcastle disease virus vaccines |
| BE853923A (fr) * | 1977-04-25 | 1977-10-25 | Rit Rech Ind Therapeut | Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation |
| EP0009277B1 (fr) * | 1978-09-14 | 1984-04-18 | Gist-Brocades N.V. | Vaccin combiné actif contre la maladie de Newcastle et contre la baisse de la ponte causée par des virus du genre adéno, procédé de préparation, souches de virus du genre adéno et de la maladie de Newcastle |
-
1979
- 1979-10-29 SU SU792833299A patent/SU826584A1/ru active
-
1980
- 1980-09-08 US US06/184,933 patent/US4279893A/en not_active Expired - Lifetime
- 1980-09-11 DE DE19803034238 patent/DE3034238A1/de not_active Ceased
- 1980-10-03 GB GB8031930A patent/GB2062461B/en not_active Expired
- 1980-10-07 CA CA000361692A patent/CA1159366A/fr not_active Expired
- 1980-10-09 NL NL8005577A patent/NL8005577A/nl not_active Application Discontinuation
- 1980-10-27 DK DK453880A patent/DK453880A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK453880A (da) | 1981-04-30 |
| SU826584A1 (ru) | 1982-11-07 |
| GB2062461B (en) | 1983-10-19 |
| US4279893A (en) | 1981-07-21 |
| GB2062461A (en) | 1981-05-28 |
| CA1159366A (fr) | 1983-12-27 |
| DE3034238A1 (de) | 1981-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4530831A (en) | Infectious Bursal Disease vaccine | |
| Vakharia et al. | Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins | |
| US4224412A (en) | Living virus culture vaccine against canine distemper and method of preparing same | |
| JP7354106B2 (ja) | レプリコン粒子および油性アジュバントによるワクチン接種 | |
| IE53872B1 (en) | Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain | |
| US4751079A (en) | Infectious bronchitis vaccines | |
| NO153010B (no) | Fremgngsmaate for fremstilling av vaksine mot newcastle-sykdom i fjaerkre | |
| US4302444A (en) | Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines | |
| NL8005577A (nl) | Werkwijze voor het bereiden van een vaccin. | |
| US4320115A (en) | Rabies virus vaccine | |
| JP3945842B2 (ja) | 弱毒性ニューカッスル病ウイルスワクチン | |
| CZ282443B6 (cs) | Očkovací látka pro prevenci infekční bursitidy u drůbeže a způsob její výroby | |
| Mazija et al. | Immunogenicity and safety of Queensland V4 and Ulster 2C strains of Newcastle disease virus given to maternally immune, newly hatched chickens by nebulization | |
| Crick | The vaccination of man and other animals against rabies | |
| RU2127603C1 (ru) | Инактивированная вакцина против инфекционной бурсальной болезни птиц | |
| RU2323741C2 (ru) | Вакцина против гриппа птиц инактивированная эмульсионная | |
| RU2233671C1 (ru) | Инактивированная вакцина против синдрома снижения яйценоскости-76 птиц | |
| JPS6244528B2 (fr) | ||
| RU2239452C2 (ru) | Способ изготовления инактивированной вакцины против синдрома снижения яйценоскости-76 птиц | |
| RU2283136C2 (ru) | Инактивированная сорбированная вакцина против инфекционной бурсальной болезни птиц | |
| KR810001063B1 (ko) | 생 뉴캣슬(Newcastle)병 바이러스 백신의 제법 | |
| RU2283137C2 (ru) | Инактивированная эмульсионная вакцина против инфекционной бурсальной болезни птиц | |
| RU2236255C1 (ru) | Культуральная вирусвакцина против ньюкаслской болезни | |
| RU2193062C1 (ru) | Штамм кр 95 № 114 вируса синдрома гидроперикардита кур для изготовления вакцинных препаратов | |
| RU2221865C1 (ru) | Штамм "бисс № 113" вируса синдрома снижения яйценоскости - 76 птиц для изготовления вакцинных препаратов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1A | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| A85 | Still pending on 85-01-01 | ||
| BI | The patent application has been withdrawn |